CARAMEL Observational Study
Recruiting
Observational Study
Perimenopause
Menopause
Cardiovascular (CV) Risk
Women (Between 30 to 60 Years Old)
Cardiovascular Disease Risk Factor
Artificial Intelligence (Al)
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Healthy Volunteers Welcome
You do not need to have the condition being studied to take part.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 40 – 60
- Sex
- Female
- Study type
- Observational
- Participants needed
- 3,000 (estimated)
- Sponsor
- Biogipuzkoa Health Research Institute · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
CARAMEL is a project funded by the European Commission under the Horizon Europe programme. Its aim is to develop a personalized prevention approach based on state-of-the-art artificial intelligence models for cardiovascular risk stratification in women aged 40-60 years. These models are trained using large amounts of multi-source data and complemented by digital self-assessment and self-management…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Women 40 to 60 years of age, at recruitment.
* Ability to understand and complete the required informed consent for the study.
* Women who are covered by the corresponding healthcare system operating at each clinical site.
Exclusion Criteria:
* Severe comorbidity with less t…
Contacts